BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22847191)

  • 1. MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis.
    Liu Y; Zhao J; Zhang PY; Zhang Y; Sun SY; Yu SY; Xi QS
    Med Sci Monit; 2012 Aug; 18(8):BR299-308. PubMed ID: 22847191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
    Pan Y; Li J; Zhang Y; Wang N; Liang H; Liu Y; Zhang CY; Zen K; Gu H
    Sci Rep; 2016 May; 6():25798. PubMed ID: 27174021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
    Ma L; Teruya-Feldstein J; Weinberg RA
    Nature; 2007 Oct; 449(7163):682-8. PubMed ID: 17898713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 10b promotes abnormal expression of the proto-oncogene c-Jun in metastatic breast cancer cells.
    Knirsh R; Ben-Dror I; Modai S; Shomron N; Vardimon L
    Oncotarget; 2016 Sep; 7(37):59932-59944. PubMed ID: 27494896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of miR-10b in transforming growth factor-β1-induced epithelial-mesenchymal transition in breast cancer.
    Han X; Yan S; Weijie Z; Feng W; Liuxing W; Mengquan L; Qingxia F
    Cancer Gene Ther; 2014 Feb; 21(2):60-7. PubMed ID: 24457988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-10b Directly Targets ZEB1 and PIK3CA to Curb Adenomyotic Epithelial Cell Invasiveness via Upregulation of E-Cadherin and Inhibition of Akt Phosphorylation.
    Guo Y; Lang X; Lu Z; Wang J; Li T; Liao Y; Jia C; Zhao W; Fang H
    Cell Physiol Biochem; 2015; 35(6):2169-80. PubMed ID: 25896413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
    Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH
    J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
    Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F
    Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
    Piperigkou Z; Franchi M; Götte M; Karamanos NK
    Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism.
    Ibrahim SA; Yip GW; Stock C; Pan JW; Neubauer C; Poeter M; Pupjalis D; Koo CY; Kelsch R; Schüle R; Rescher U; Kiesel L; Götte M
    Int J Cancer; 2012 Sep; 131(6):E884-96. PubMed ID: 22573479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
    Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA
    Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin.
    Zhang J; Xu L; Yang Z; Lu H; Hu D; Li W; Zhang Z; Liu B; Ma S
    Clin Transl Oncol; 2015 Mar; 17(3):209-14. PubMed ID: 25214146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
    Fan X; Huang X; Li Z; Ma X
    J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
    Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.
    Parrella P; Barbano R; Pasculli B; Fontana A; Copetti M; Valori VM; Poeta ML; Perrone G; Righi D; Castelvetere M; Coco M; Balsamo T; Morritti M; Pellegrini F; Onetti-Muda A; Maiello E; Murgo R; Fazio VM
    Mol Cancer; 2014 Jun; 13():142. PubMed ID: 24897960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA-10b sponge: An anti-breast cancer study in vitro.
    Liang AL; Zhang TT; Zhou N; Wu CY; Lin MH; Liu YJ
    Oncol Rep; 2016 Apr; 35(4):1950-8. PubMed ID: 26820121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin.
    Zhao Z; Fan X; Jiang L; Xu Z; Xue L; Zhan Q; Song Y
    J Genet Genomics; 2017 Feb; 44(2):75-84. PubMed ID: 28161325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
    Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
    Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.